Japan Glucose Monitoring Devices Market Size, Share, By Product Type (Self-Monitoring Glucose Devices, Glucometers, Test Strips, Lancets, and Continuous Glucose Monitoring Devices, Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), By Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), By End User (Home Care Settings, Hospitals, and Others), Japan Glucose Monitoring Devices Market Industry Trend, Forecasts to 2035.
Industry: Chemicals & MaterialsJapan Glucose Monitoring Devices Market Insights Forecasts to 2035
- Japan Glucose Monitoring Devices Market Size 2024: USD 909.34 Million
- Japan Glucose Monitoring Devices Market Size 2035: USD 2412.12 Million
- Japan Glucose Monitoring Devices Market CAGR 2024: 9.27%
- Japan Glucose Monitoring Devices Market Segments: Product Type, Application and End Use.

Get more details on this report -
The Japan Glucose Monitoring Devices Market Size includes medical devices that are used by diabetic patients to check their blood glucose levels. The device range includes both basic glucose monitors and advanced continuous glucose monitoring systems. The diabetes management devices assist both patients and doctors to achieve better diabetes control. The Japan glucose monitoring devices market is expanding because more people in Japan develop diabetes through their changing lifestyles and the increasing number of older citizens. Furthermore, the Japan glucose monitoring devices The market growth is driven by two factors which include technological advancements in wearable glucose monitoring devices and increased public awareness of healthcare. Patients now prefer home-based glucose monitoring methods because these methods better support their diabetes control and help them prevent health problems.
The Japan government is promoting better diabetes management and prevention through health programs that create awareness about glucose monitoring devices, which receive insurance coverage. The rising coverage of continuous glucose monitoring devices together with diabetes management devices, has made these medical services more affordable for patients throughout the United States. Public health campaigns are also promoting early detection and the integration of digital health to improve the management of chronic diseases.
Japan Glucose Monitoring Devices Market Size trends in Japan for glucose monitoring devices show that people increasingly choose continuous glucose monitoring systems. The market sees increased smartphone system integration, which enables users to distribute data and receive customised health information. The combination of wearable technology and better sensor precision generates higher user interest because it provides simpler and more enjoyable ways to track glucose levels
Market Dynamics of the Japan Glucose Monitoring Devices Market:
The Japan Glucose Monitoring Devices Market Size is he Japan glucose monitoring devices market expands because more people develop diabetes, especially type 2 diabetes, The growth of the market stems from technological advancements in wearable continuous glucose monitoring devices, together with increased public knowledge about preventive healthcare methods. The combination of expanded insurance coverage and increased interest in self-managed health care solutions drives people to use advanced glucose monitoring technologies.
The Japan Glucose Monitoring Devices Market Size restraining includes relatively high costs of advanced monitoring systems compared to basic meters, regulatory requirements for medical device approval, and slow adoption among older populations unfamiliar with digital tools. Integration issues with health IT and concerns about data security and privacy may also affect user confidence and uptake.
The opportunities in the Japan glucose monitoring devices market are expanding, especially in home and wearable devices that support real-time monitoring and lifestyle applications. Digital health platforms, smartphone integration, and data analytics offer new ways to personalize care and connect patients with healthcare providers. Collaboration between technology companies and healthcare systems can further expand access and drive innovation.
Japan Glucose Monitoring Devices Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 909.34 Million |
| Forecast Period: | 2025-2035 |
| Forecast Period CAGR 2025-2035 : | CAGR Of 9.27 % |
| 2035 Value Projection: | USD 2412.12 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 110 |
| Segments covered: | By Product Type, By Application |
| Companies covered:: | Roche Diabetes Care. Abbott Laboratories. Medtronic plc. Dexcom, Inc. LifeScan (Johnson & Johnson) Terumo Corporation ArkRay, Inc. Nipro Corporation. Ascensia Diabetes Care Acon Laboratories, Inc. Other companies Other Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The Japan glucose monitoring devices market share is classified into product types, applications, and end users.
By Product Type:
The Japan Glucose Monitoring Devices Market Size is divided by product type into self-monitoring glucose devices, glucometers, test strips, lancets, and continuous glucose monitoring devices, sensors, transmitters & receivers, and integrated insulin pumps. Among these, the continuous glucose monitoring devices segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The continuous glucose monitoring devices segment dominates because they provide real-time glucose data, improve diabetes control, and reduce the need for frequent finger-prick tests. They enhance patient convenience, support better treatment decisions, and integrate with smartphones and insulin pumps. Growing preference for wearable, technology-based solutions further strengthens their market leadership.
By Application:
The Japan Glucose Monitoring Devices Market size is divided by application into type 1 diabetes, type 2 diabetes, and gestational diabetes. Among these, the type 1 diabetes segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The type 1 diabetes industry dominates due to its being more common, especially among the ageing population. Lifestyle changes, obesity, and reduced physical activity increase cases. Patients require regular glucose monitoring for long-term management. The large patient pool and continuous monitoring needs drive higher demand and market share.
By End Use:
The Japan Glucose Monitoring Devices Market Size is divided by end use into home care settings, hospitals, and others. Among these, the home care segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Home care dominates because diabetes requires daily and long-term glucose monitoring, which patients can easily perform at home. Devices like glucometers and continuous glucose monitors are portable and user-friendly. Home monitoring reduces hospital visits, lowers medical costs, saves time, and allows patients to manage their condition independently and comfortably
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the Japan glucose monitoring devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in Japan Glucose Monitoring Devices Market:
- Roche Diabetes Care.
- Abbott Laboratories.
- Medtronic plc.
- Dexcom, Inc.
- LifeScan (Johnson & Johnson)
- Terumo Corporation
- ArkRay, Inc.
- Nipro Corporation.
- Ascensia Diabetes Care
- Acon Laboratories, Inc.
- Other companies
- Other
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical insights has segmented the Japan glucose monitoring devices market based on the below-mentioned segments:
Japan Glucose Monitoring Devices Market, By Product Type.
- Self-Monitoring Glucose Devices
- Glucometers
- Test Strips
- Lancets and Continuous Glucose Monitoring Devices
- Sensors
- Transmitters & Receivers
- Integrated Insulin Pumps
Japan Glucose Monitoring Devices Market, By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Others
Japan Glucose Monitoring Devices Market, By End Use.
- Home Care Settings
- Hospitals
- Others
Frequently Asked Questions (FAQ)
-
What is the Japan glucose monitoring devices market size?Japan glucose monitoring devices market is expected to grow from USD 909.34 Million in 2024 to USD 2412.12 Million by 2035, growing at a CAGR of 9.27 % during the forecast period 2025-2035
-
What are the key growth drivers of the Japan glucose monitoring devices market?The Japan glucose monitoring devices market includes high diabetes prevalence, an ageing population, advanced technology, government support, growing health awareness, and increasing demand for home-based glucose monitoring devices.
-
What factors restrain the Japan glucose monitoring devices market?The Japan glucose monitoring devices market is High costs of continuous glucose monitoring devices, strict regulatory approval processes, limited reimbursement coverage, low digital awareness among elderly patients, and concerns about data privacy and accuracy restrain market growth
-
How is the Japan glucose monitoring devices market segmented by application?The Japan glucose monitoring devices market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes
-
Who are the key players in the Japan glucose monitoring devices market?The Japan glucose monitoring devices market includes key companies such as Roche Diabetes Care, Abbott Laboratories, Medtronic plc., Dexcom, Inc., Life Scan (Johnson & Johnson), Terumo Corporation, ArkRay, Inc., Nipro Corporation, Ascensia Diabetes Care, Acon Laboratories, Inc., and other
Need help to buy this report?